Xlife Sciences AG

BATS-CHIXE:XLSZ Stock Report

Market Cap: CHF 135.5m

Xlife Sciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Oliver Baumann

Chief executive officer

CHF 716.8k

Total compensation

CEO salary percentage42.5%
CEO tenure4.6yrs
CEO ownership7.0%
Management average tenure3.1yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Oliver Baumann's remuneration changed compared to Xlife Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CHF 21m

Mar 31 2024n/an/a

CHF 18m

Dec 31 2023CHF 717kCHF 305k

CHF 15m

Sep 30 2023n/an/a

CHF 16m

Jun 30 2023n/an/a

CHF 16m

Mar 31 2023n/an/a

CHF 15m

Dec 31 2022CHF 597kCHF 305k

CHF 14m

Sep 30 2022n/an/a

CHF 32m

Jun 30 2022n/an/a

CHF 49m

Mar 31 2022n/an/a

CHF 51m

Dec 31 2021CHF 1mCHF 284k

CHF 53m

Compensation vs Market: Oliver's total compensation ($USD790.57K) is above average for companies of similar size in the UK market ($USD348.02K).

Compensation vs Earnings: Oliver's compensation has increased by more than 20% in the past year.

CEO

Oliver Baumann

4.6yrs

Tenure

CHF 716,786

Compensation

Mr. Oliver R. Baumann serves as Chief Executive Officer at Xlife Sciences AG. He serves as Director at Xlife Sciences AG since June 17, 2020. He is a certified banking economist and passionate entrepreneur...

Leadership Team

NamePositionTenureCompensationOwnership
Oliver Baumann
CEO & Executive Directorno dataCHF 716.79k6.99%
CHF 9.5m
Carl Halem
Chief Financial Officer3.1yrsno datano data
Beat Klaui
Head of Accounting & Taxation4yrsno datano data
Alexander Zink
Head of Technology & Innovation2yrsno datano data
Frank Ploger
Chief Scientific Officer4.2yrsno datano data
Dennis Fink
Senior Communications & Investor Relations Managerno datano datano data
Christian Faber
Chief Compliance Officer and Head of Legal & Compliance3yrsCHF 50.69kno data

3.1yrs

Average Tenure

Experienced Management: XLSZ's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Oliver Baumann
CEO & Executive Director4.6yrsCHF 716.79k6.99%
CHF 9.5m
Hans-Georg Rammensee
Member of the Advisory Boardno datano datano data
Michael Klein
Chairman of Advisory Baordno dataCHF 24.43kno data
Ernst Rietschel
Member of the Advisory Boardno datano datano data
Johannes Schumacher
Member of the Advisory Boardno datano datano data
Ralf Oettmeier
Member of the Advisory Boardno datano datano data
Uwe Rudolf Reuter
Member of the Advisory Boardno datano datano data
Christoph Brucher
Member of the Advisory Boardno datano datano data
Mark Muller
Non-Executive Independent Director6.3yrsCHF 48.61kno data
David Deck
President of the Board of Directors2.6yrsCHF 425.77k22.97%
CHF 31.1m
Desiree Dosch
Independent Non-Executive Director2.6yrsCHF 48.61kno data
Norbert Windhab
Non-Executive Director2.6yrsCHF 51.60kno data

2.6yrs

Average Tenure

Experienced Board: XLSZ's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 13:22
End of Day Share Price 2025/01/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xlife Sciences AG is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel JelovcanStifel, Equities Research
Ulrich HuwaldWarburg Research GmbH